Overcoming barriers to nonadherence in asthma treatment

Slides:

Advertisements

Similar presentations

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Advertisements

Comparative outcomes of leukotriene receptor antagonists and long-acting β-agonists as add-on therapy in asthmatic patients: A population-based study

Recognition and First-Line Treatment of Anaphylaxis

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial

Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M

Genetics and the variability of treatment response in asthma

Rohit K. Katial, MD, Greg W. Bensch, MD, William W

The epidemiology of the atopic child

Comparative efficacy and anti-inflammatory profile of once-daily therapy with leukotriene antagonist or low-dose inhaled corticosteroid in patients with.

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD

Inhibitory effect of a leukotriene receptor antagonist (montelukast) on neurokinin a- induced bronchoconstriction Nunzio Crimi, MD, Corrado Pagano, MD,

Aspirin-induced urticaria and angioedema, but not bronchoconstriction, associated with cysteinyl leukotriene overproduction in 2 patients with asthma

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Is 9 more than 2 also in allergic airway inflammation?

David P. Skoner, MD, Betty L

Badrul A. Chowdhury, MD, PhD

NAEPP Expert Panel Report

Elephantiasis nostras: A case report

Adverse effects of β-agonists

Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthma Bradley E. Chipps, MD, Stanley J. Szefler,

The impact of allergic rhinitis on bronchial asthma

Nonadherence to Asthma Treatment: Getting Unstuck

The chlorofluorocarbon to hydrofluoroalkane transition: The effect on pressurized metered dose inhaler suspension stability Anne Brindley, BPharm, MRPharmS,

Inhaled corticosteroids: Impact on asthma morbidity and mortality

Omalizumab, an Anti-IgE mAb, Receives Approval for the Treatment of Chronic Idiopathic/Spontaneous Urticaria Keith C.P. Wu, Zarif K. Jabbar-Lopez Journal.

Peter König, MD, PhD Journal of Allergy and Clinical Immunology

Paul M. O’Byrne, MB, FRCPI, FRCP(C)a, Soren Pedersen, MD, PhDb

Airway inflammation in asthma and its consequences: Implications for treatment in children and adults Ratko Djukanovic, MD Journal of Allergy and Clinical.

A review of the current guidelines for allergic rhinitis and asthma

Physician-targeted program on inhaled therapy for childhood asthma

News & Notes Journal of Allergy and Clinical Immunology

Circadian variation of sputum inflammatory cells in mild asthma

Direct exposure of carpets to sunlight can kill all mites

Inflammatory cells, cytokine and chemokine expression in asthma immunocytochemistry and in situ hybridization Qutayba Hamid, MD, PhD, Editor Journal.

Effect of β-adrenergic agonists on mucociliary clearance

6. Asthma Journal of Allergy and Clinical Immunology

Claus Bachert, MD, PhD, Cezmi A. Akdis, MD

Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think Martin L. Moore, PhD, R.

Effects of β2-agonists on airway tone and bronchial responsiveness

Clinical need for a nebulized corticosteroid

H. William Kelly, PharmD Journal of Allergy and Clinical Immunology

News & Notes Journal of Allergy and Clinical Immunology

Adherence with montelukast or fluticasone in a long-term clinical trial: Results from the Mild Asthma Montelukast Versus Inhaled Corticosteroid Trial

Advances in the approach to the patient with food allergy

Observations on emerging patterns of asthma in our society

Inhaled corticosteroids and allergy specialty care reduce emergency hospital use for asthma Michael Schatz, MD, MSa, E.Francis Cook, DScb, Randy Nakahiro,

Clinical effects of nedocromil sodium on challenges invoking neuronal mechanisms and on virally induced symptoms Peter König, MD, PhD Journal of Allergy.

Bruce G. Bender, PhD, Alex Pedan, PhD, Laleh T. Varasteh, RPh, MSF

Effects of cysteinyl leukotrienes and leukotriene receptor antagonists on markers of inflammation Anthony P. Sampson, PhDa, Emilio Pizzichini, MD, PhDb,

The role and remediation of animal allergens in allergic diseases

Exercise-induced asthma: Is it the right diagnosis in elite athletes?

Preparing patients and health professionals for the transition to chlorofluorocarbon-free inhalers: The British perspective Helen Donohoe, MSc (Econ)

Leukotriene receptor antagonists in asthma therapy

Erika von Mutius, MD Journal of Allergy and Clinical Immunology

Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.

Robert P. Schleimer, PhD Journal of Allergy and Clinical Immunology

Abnormalities of cell and mediator levels in bronchoalveolar lavage fluid of patients with mild asthma Sally E. Wenzel, MD Journal of Allergy and Clinical.

Further studies on the chronotherapy of asthma with inhaled steroids: The effect of dosage timing on drug efficacy Diane J. Pincus, MD, Teresa R. Humeston,

Diane J. Pincus, MD, Stanley J. Szefler, MD, Lynn M

10. Drug allergy Journal of Allergy and Clinical Immunology

National trends in asthma visits and asthma pharmacotherapy,

Managing asthma exacerbations in the emergency department: Summary of the National Asthma Education and Prevention Program Expert Panel Report 3 guidelines.

Macrolide antibiotics and asthma treatment

Larry C. Borish, MDa, Harold S

Severe asthma: Lessons from the Severe Asthma Research Program

News & Notes Journal of Allergy and Clinical Immunology

Lisa A. Beck, MD, Sarbjit Saini, MD

Negative affect, medication adherence, and asthma control in children

Natural history of cow’s milk allergy

Mepolizumab efficacy in patients with severe eosinophilic asthma receiving different controller therapies Frank C. Albers, MD, PhD, Robert G. Price,

Presentation transcript:

Overcoming barriers to nonadherence in asthma treatment Bruce G. Bender, PhD Journal of Allergy and Clinical Immunology Volume 109, Issue 6, Pages S554-S559 (June 2002) DOI: 10.1067/mai.2002.124570 Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 1 Comparison of four adherence measures over 6 months. Data from the Doser CT were compared with other measures of adherence and revealed a mean adherence rate of slightly more than 50%. (Adapted with permission of Ann Allergy Asthma Immunol 2000;85:416-21. Copyright 2000.) Journal of Allergy and Clinical Immunology 2002 109, S554-S559DOI: (10.1067/mai.2002.124570) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 2 Adherence as determined by prescription refill. Prescription refill rates were substantially higher with leukotriene receptor antagonists in a study examining the prescription refill rates for 3 different medication categories: leukotriene receptor antagonists, long-acting β-agonists, and inhaled corticosteroids. (Data compiled from Drazen et al.7) Journal of Allergy and Clinical Immunology 2002 109, S554-S559DOI: (10.1067/mai.2002.124570) Copyright © 2002 Mosby, Inc. Terms and Conditions

Fig. 3 Percent of patients adhering to asthma therapy in the United Kingdom. In a comparison of prescription refill rates of the leukotriene receptor antagonist montelukast and those of an inhaled β-blocker and a corticosteroid, refill rates varied from 45% for montelukast, to 32% for the β-blocker, and to 17% for the corticosteroid. (From Price D, Ben-Joseph R, Zhang Q. Adherence to prescribed treatment for asthma [abstract]. Am J Respir Crit Care Med 2000;161:A402. Poster presented at American Thoracic Society; May 8, 2000; Toronto. With permission.) Journal of Allergy and Clinical Immunology 2002 109, S554-S559DOI: (10.1067/mai.2002.124570) Copyright © 2002 Mosby, Inc. Terms and Conditions